RIGL - RIGEL PHARMACEUTICALS INC
19.91
-0.520 -2.612%
Share volume: 146,445
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$20.43
-0.52
-0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-02-2023 | 08-01-2023 | 11-07-2023 | 03-05-2024 | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-04-2025 | |
| Assets | |||||||||
| Total Assets | 123.612 M | 117.091 M | 115.324 M | 117.225 M | 126.519 M | 128.408 M | 139.419 M | 163.976 M | |
| Current Assets | 106.972 M | 100.925 M | 95.024 M | 99.266 M | 92.486 M | 94.723 M | 106.467 M | 135.103 M | |
| Inventories | 11.077 M | 10.782 M | 6.112 M | 5.522 M | 6.579 M | 8.059 M | 4.784 M | 6.002 M | |
| Other Current Assets | 7.867 M | 4.967 M | 3.015 M | 6.261 M | 8.845 M | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 7.867 M | 4.967 M | 3.015 M | 6.261 M | 8.845 M | 13.049 M | 9.422 M | 20.575 M | |
| Total Receivables | 29.366 M | 20.819 M | 23.546 M | 30.550 M | 27.512 M | 0.000 | 0.000 | 0.000 | |
| Current Cash | 58.662 M | 64.357 M | 62.351 M | 56.933 M | 49.550 M | 36.053 M | 51.692 M | 56.746 M | |
| Total Non-current Assets | 16.640 M | 16.166 M | 20.300 M | 17.959 M | 34.033 M | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 294.000 K | 215.000 K | 190.000 K | 165.000 K | 140.000 K | 115.000 K | 99.000 K | 92.000 K | |
| Other Assets | 542.000 K | 541.000 K | 4.956 M | 3.055 M | 4.318 M | 33.570 M | 32.853 M | 28.781 M | |
| Intangible Assets | 14.681 M | 14.413 M | 14.146 M | 13.878 M | 28.863 M | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 123.612 M | 117.091 M | 115.324 M | 117.225 M | 126.519 M | 128.408 M | 139.419 M | 163.976 M | |
| Total liabilities | 147.869 M | 145.206 M | 147.158 M | 145.869 M | 158.190 M | 158.322 M | 154.055 M | 160.688 M | |
| Total current liabilities | 45.518 M | 44.023 M | 48.273 M | 53.267 M | 73.198 M | 58.649 M | 54.312 M | 63.299 M | |
| Accounts Payable | 6.295 M | 5.240 M | 7.999 M | 7.142 M | 9.276 M | 6.130 M | 3.815 M | 3.339 M | |
| Other liabilities | 42.065 M | 40.981 M | 38.760 M | 39.944 M | 39.982 M | 39.981 M | 39.981 M | 44.981 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 7.229 M | 14.780 M | 0.000 | 0.000 | 0.000 | |
| Long term debt | 59.484 M | 59.574 M | 59.659 M | 52.373 M | 44.910 M | 59.692 M | 59.762 M | 52.408 M | |
| Other liabilities | 42.065 M | 40.981 M | 38.760 M | 39.944 M | 39.982 M | 39.981 M | 39.981 M | 44.981 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -24.257 M | -28.115 M | -31.834 M | -28.644 M | -31.671 M | -29.914 M | -14.636 M | 3.288 M | |
| Common stock | 173.568 M | 173.748 M | 174.364 M | 174.388 M | 175.203 M | 1.387 B | 1.390 B | 1.393 B | |
| Retained earnings | -1.396 B | -1.403 B | -1.408 B | -1.408 B | -1.416 B | -1.417 B | -1.404 B | -1.390 B |